<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7282336\results\search\disease\results.xml">
  <result pre="no general disease history, OR 1.19, 95% CI 1.14 to 1.25)," exact="obesity" post="(vs normal weight, OR 0.91, 95% CI 0.86 to 0.97);"/>
  <result pre="(vs normal weight, OR 0.91, 95% CI 0.86 to 0.97); and" exact="hepatitis" post="B antibody seropositivity (OR 2.39, 95% CI 2.31 to 2.49)."/>
  <result pre="IgG seropositivity points to a need for implementation of workplace-based" exact="hepatitis" post="A vaccine programmes. To promote workers’ health and prevent"/>
  <result pre="hepatitis A vaccine programmes. To promote workers’ health and prevent" exact="hepatitis" post="A outbreaks, occupational health managers, healthcare providers and policy-makers"/>
  <result pre="difficult to determine causal interference. Background According to the WHO," exact="hepatitis" post="A caused an estimated 7134 deaths in 2016. Hepatitis"/>
  <result pre="estimated 7134 deaths in 2016. Hepatitis A is a viral" exact="liver disease" post="caused by hepatitis A virus (HAV). Globally, HAV infection"/>
  <result pre="2016. Hepatitis A is a viral liver disease caused by" exact="hepatitis" post="A virus (HAV). Globally, HAV infection occurs sporadically and"/>
  <result pre="is susceptible to HAV infection.2 There were 14 214 cases of" exact="hepatitis" post="A reported to the Korea Centers for Disease Control"/>
  <result pre="Immunity against HAV is acquired after complete recovery from acute" exact="hepatitis" post="A and when properly vaccinated. Notwithstanding its relatively low"/>
  <result pre="(figure 1). Figure 1 Flow chart of participant selection. HAV," exact="hepatitis" post="A virus; IgG, immunoglobulin G. Measurement of variables Data"/>
  <result pre="index (BMI), waist circumference, fasting glucose, total cholesterol, presence of" exact="hepatitis" post="B surface antibody (HBsAb) and anti-HAV IgG measured by"/>
  <result pre="disease history such as stroke, cardiac disease, hypertension, diabetes, cancer," exact="pulmonary tuberculosis," post="dyslipidaemia and any chronic or acute disease history were"/>
  <result pre="three categories: normal, &amp;lt;25 kg/m2; overweight, 25–29.9 kg/m2; and obese, ≥30 kg/m2. Abdominal" exact="obesity" post="was defined by waist circumference:&amp;gt;90 cm for men and &amp;gt;85 cm"/>
  <result pre="by waist circumference:&amp;gt;90 cm for men and &amp;gt;85 cm for women. Normal," exact="glucose intolerance" post="and suspected diabetes were defined as a fasting blood"/>
  <result pre="HBsAb positive. None of the participants reported a history of" exact="hepatitis" post="A. The overall seroprevalence of anti-HAV IgG (hereinafter seroprevalence)"/>
  <result pre="(66.3) 19 772 (43.5) 25 729 (56.5) BMI, body mass index; HAV," exact="hepatitis" post="A virus; HBsAb, hepatitis B surface antibody; IgG, immunoglobulin"/>
  <result pre="(56.5) BMI, body mass index; HAV, hepatitis A virus; HBsAb," exact="hepatitis" post="B surface antibody; IgG, immunoglobulin G; IQR, interquartile range."/>
  <result pre="(64.2) *Occupational classifications with &amp;lt;50 workers are not shown. HAV," exact="hepatitis" post="A virus; IgG, immunoglobulin G. Factors associated with the"/>
  <result pre="fully adjusted logistic regression model, age, sex, BMI, disease history," exact="hepatitis" post="B status, occupational classification and number of workplace health"/>
  <result pre="2.68); female sex (OR 1.54, 95% CI 1.48 to 1.59); and" exact="hepatitis" post="B antibody seropositivity (OR 2.39, 95% CI 2.31 to 2.49)"/>
  <result pre="0.91 (0.86 to 0.97) Waist circumference  Normal 1.00 (reference)  Abdominal" exact="obesity" post="0.94 (0.90 to 0.98) Fasting glucose  Normal 1.00 (reference)"/>
  <result pre="values. †P for trend &amp;lt;0.001. BMI, body mass index; HBsAb," exact="hepatitis" post="B surface antibody. Discussion Principal findings The overall seroprevalence"/>
  <result pre="to WHO in 2009, the estimated prevalence of immunity against" exact="hepatitis" post="A in Korea increased with age, from 25% among"/>
  <result pre="IgG than men. In Korea, a survey of the national" exact="influenza" post="vaccination rate revealed that the rate was higher among"/>
  <result pre="studies have directly proved the relationship between personal behaviour and" exact="hepatitis" post="A vaccination yet. Indeed, anti-HAV seroprevalence differed significantly by"/>
  <result pre="need for further longitudinal studies. Second, it was unknown whether" exact="hepatitis" post="A IgG antibody seropositivity of participants was acquired by"/>
  <result pre="Centers for Disease Control and PreventionIn-Depth epidemiologic survey results for" exact="hepatitis" post="A outbreaks in 2019. Available: https://www.cdc.go.kr/board.es?mid=a20501000000&amp;amp;bid=0015&amp;amp;act=view&amp;amp;list_no=364837# [Accessed 14 Oct"/>
  <result pre="8). JAMA2014;311:507–20. 10.1001/jama.2013.28442724352797 6collab: World Health OrganisationThe global prevalence of" exact="hepatitis" post="A virus infection and susceptibility: a systematic review. Available:"/>
  <result pre="Trop Med Hyg2015;109:9–15. 10.1093/trstmh/tru16725573105 9YunH, LeeH-J, CheonD, et al.Seroprevalence of" exact="hepatitis" post="A and E viruses based on the third Korea"/>
 </snippets>
</snippetsTree>
